Genetic variation in Chlamydia trachomatis and their hosts: impact on disease severity and tissue tropism.

PubWeight™: 0.95‹?› | Rank: Top 15%

🔗 View Article (PMC 4009991)

Published in Future Microbiol on September 01, 2013

Authors

Hossam Abdelsamed1, Jan Peters1,2, Gerald I Byrne1,2

Author Affiliations

1: Department of Microbiology, Immunology & Biochemistry, University of Tennessee Health Sciences Center, Memphis, TN, USA.
2: Regional Biocontainment Laboratory, University of Tennessee Health Sciences Center, Memphis, TN, USA.

Articles citing this

Global Multilocus Sequence Type Analysis of Chlamydia trachomatis Strains from 16 Countries. J Clin Microbiol (2015) 0.89

Chlamydia trachomatis and Genital Mycoplasmas: Pathogens with an Impact on Human Reproductive Health. J Pathog (2014) 0.86

No indication for tissue tropism in urogenital and anorectal Chlamydia trachomatis infections using high-resolution multilocus sequence typing. BMC Infect Dis (2014) 0.84

Membrane vesicle production by Chlamydia trachomatis as an adaptive response. Front Cell Infect Microbiol (2014) 0.83

Chlamydia trachomatis from Australian Aboriginal people with trachoma are polyphyletic composed of multiple distinctive lineages. Nat Commun (2016) 0.83

Discovery of a Natural Microsporidian Pathogen with a Broad Tissue Tropism in Caenorhabditis elegans. PLoS Pathog (2016) 0.82

Comparable Genital Tract Infection, Pathology, and Immunity in Rhesus Macaques Inoculated with Wild-Type or Plasmid-Deficient Chlamydia trachomatis Serovar D. Infect Immun (2015) 0.79

Chlamydia trachomatis Is Resistant to Inclusion Ubiquitination and Associated Host Defense in Gamma Interferon-Primed Human Epithelial Cells. MBio (2016) 0.78

Exploiting ovine immunology to improve the relevance of biomedical models. Mol Immunol (2014) 0.78

Association of Genital Infections Other Than Human Papillomavirus with Pre-Invasive and Invasive Cervical Neoplasia. J Clin Diagn Res (2016) 0.77

High Frequency of Latent Conjunctival C. trachomatis, M. hominis, and U. urealyticum Infections in Young Adults with Dry Eye Disease. J Ophthalmol (2014) 0.76

Does typing of Chlamydia trachomatis using housekeeping multilocus sequence typing reveal different sexual networks among heterosexuals and men who have sex with men? BMC Infect Dis (2016) 0.75

Exploiting induced pluripotent stem cell-derived macrophages to unravel host factors influencing Chlamydia trachomatis pathogenesis. Nat Commun (2017) 0.75

Microbiota composition of the koala (Phascolarctos cinereus) ocular and urogenital sites, and their association with Chlamydia infection and disease. Sci Rep (2017) 0.75

Global survey of mRNA levels and decay rates of Chlamydia trachomatis trachoma and lymphogranuloma venereum biovars. Heliyon (2017) 0.75

Articles cited by this

(truncated to the top 100)

Initial sequencing and comparative analysis of the mouse genome. Nature (2002) 96.15

Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A (2013) 16.74

Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science (1998) 13.64

Immunologic relationship between genital TRIC, lymphogranuloma venereum, and related organisms in a new microtiter indirect immunofluorescence test. Am J Ophthalmol (1970) 10.68

Type III secretion machines: bacterial devices for protein delivery into host cells. Science (1999) 9.10

Chlamydia trachomatis infections in female military recruits. N Engl J Med (1998) 4.68

Induction of tryptophan catabolism is the mechanism for gamma-interferon-mediated inhibition of intracellular Chlamydia psittaci replication in T24 cells. Infect Immun (1986) 4.34

Genome sequence of Chlamydophila caviae (Chlamydia psittaci GPIC): examining the role of niche-specific genes in the evolution of the Chlamydiaceae. Nucleic Acids Res (2003) 4.33

Genomic transcriptional profiling of the developmental cycle of Chlamydia trachomatis. Proc Natl Acad Sci U S A (2003) 4.00

A chlamydial type III translocated protein is tyrosine-phosphorylated at the site of entry and associated with recruitment of actin. Proc Natl Acad Sci U S A (2004) 3.44

A Chlamydia trachomatis strain with a 377-bp deletion in the cryptic plasmid causing false-negative nucleic acid amplification tests. Sex Transm Dis (2007) 3.39

The chlamydial developmental cycle. FEMS Microbiol Rev (2005) 3.08

Polymorphisms in Chlamydia trachomatis tryptophan synthase genes differentiate between genital and ocular isolates. J Clin Invest (2003) 3.04

Three temporal classes of gene expression during the Chlamydia trachomatis developmental cycle. Mol Microbiol (2000) 2.71

Whole-genome analysis of diverse Chlamydia trachomatis strains identifies phylogenetic relationships masked by current clinical typing. Nat Genet (2012) 2.44

How protein stability and new functions trade off. PLoS Comput Biol (2008) 2.41

Chlamydial IFN-gamma immune evasion is linked to host infection tropism. Proc Natl Acad Sci U S A (2005) 2.34

Evolution of Chlamydia trachomatis diversity occurs by widespread interstrain recombination involving hotspots. Genome Res (2006) 2.32

Plasmid-deficient Chlamydia muridarum fail to induce immune pathology and protect against oviduct disease. J Immunol (2007) 2.30

A variant of Chlamydia trachomatis with deletion in cryptic plasmid: implications for use of PCR diagnostic tests. Euro Surveill (2006) 2.30

Phylogenetic analysis of the Chlamydia trachomatis major outer membrane protein and examination of potential pathogenic determinants. Infect Immun (1998) 2.27

Molecular basis defining human Chlamydia trachomatis tissue tropism. A possible role for tryptophan synthase. J Biol Chem (2002) 2.23

Identification and characterization of a Chlamydia trachomatis early operon encoding four novel inclusion membrane proteins. Mol Microbiol (1999) 2.18

The Chlamydophila abortus genome sequence reveals an array of variable proteins that contribute to interspecies variation. Genome Res (2005) 2.12

Chlamydia trachomatis induces remodeling of the actin cytoskeleton during attachment and entry into HeLa cells. Infect Immun (2002) 2.12

Mammalian 14-3-3beta associates with the Chlamydia trachomatis inclusion membrane via its interaction with IncG. Mol Microbiol (2001) 2.10

Host genetic variation affects resistance to infection with a highly pathogenic H5N1 influenza A virus in mice. J Virol (2009) 2.08

Type III secretion à la Chlamydia. Trends Microbiol (2007) 2.08

Impact of recombination on bacterial evolution. Trends Microbiol (2010) 1.98

Whole-genome sequences of Chlamydia trachomatis directly from clinical samples without culture. Genome Res (2013) 1.96

Population-based genetic and evolutionary analysis of Chlamydia trachomatis urogenital strain variation in the United States. J Bacteriol (2004) 1.94

Translocation of DNA across bacterial membranes. Microbiol Rev (1994) 1.94

Molecular and mutation trends analyses of omp1 alleles for serovar E of Chlamydia trachomatis. Implications for the immunopathogenesis of disease. J Clin Invest (1997) 1.93

Characterization of Chlamydia trachomatis omp1 genotypes among sexually transmitted disease patients in Sweden. J Clin Microbiol (2001) 1.90

Pathogenesis of genital tract disease due to Chlamydia trachomatis. J Infect Dis (2010) 1.87

Chlamydia trachomatis cytotoxicity associated with complete and partial cytotoxin genes. Proc Natl Acad Sci U S A (2001) 1.85

Polymorphic proteins of Chlamydia spp.--autotransporters beyond the Proteobacteria. Trends Microbiol (2001) 1.82

Chlamydial TARP is a bacterial nucleator of actin. Proc Natl Acad Sci U S A (2006) 1.81

Isolates of Chlamydia trachomatis that occupy nonfusogenic inclusions lack IncA, a protein localized to the inclusion membrane. Infect Immun (2000) 1.78

Co-evolution of genomes and plasmids within Chlamydia trachomatis and the emergence in Sweden of a new variant strain. BMC Genomics (2009) 1.78

CDC Grand Rounds: Chlamydia prevention: challenges and strategies for reducing disease burden and sequelae. MMWR Morb Mortal Wkly Rep (2011) 1.77

Characterization of fifty putative inclusion membrane proteins encoded in the Chlamydia trachomatis genome. Infect Immun (2008) 1.77

Interferon-induced indoleamine 2,3-dioxygenase activity inhibits Chlamydia psittaci replication in human macrophages. J Interferon Res (1989) 1.74

The lipid transfer protein CERT interacts with the Chlamydia inclusion protein IncD and participates to ER-Chlamydia inclusion membrane contact sites. PLoS Pathog (2011) 1.74

Genome sequencing of recent clinical Chlamydia trachomatis strains identifies loci associated with tissue tropism and regions of apparent recombination. Infect Immun (2010) 1.71

Recombination in the ompA gene but not the omcB gene of Chlamydia contributes to serovar-specific differences in tissue tropism, immune surveillance, and persistence of the organism. J Bacteriol (2001) 1.70

Polymorphisms in the nine polymorphic membrane proteins of Chlamydia trachomatis across all serovars: evidence for serovar Da recombination and correlation with tissue tropism. J Bacteriol (2006) 1.70

A live-attenuated chlamydial vaccine protects against trachoma in nonhuman primates. J Exp Med (2011) 1.70

Polymorphisms in the Chlamydia trachomatis cytotoxin locus associated with ocular and genital isolates. Infect Immun (2004) 1.68

Characterization of ompA genotypes by sequence analysis of DNA from all detected cases of Chlamydia trachomatis infections during 1 year of contact tracing in a Swedish County. J Clin Microbiol (2004) 1.68

Computational analysis of the polymorphic membrane protein superfamily of Chlamydia trachomatis and Chlamydia pneumoniae. Microb Comp Genomics (1999) 1.66

Chlamydia and apoptosis: life and death decisions of an intracellular pathogen. Nat Rev Microbiol (2004) 1.63

The GTPase Rab4 interacts with Chlamydia trachomatis inclusion membrane protein CT229. Infect Immun (2006) 1.60

The natural history of untreated Chlamydia trachomatis infection in the interval between screening and returning for treatment. Sex Transm Dis (2008) 1.60

Gene knockout B cell-deficient mice demonstrate that B cells play an important role in the initiation of T cell responses to Chlamydia trachomatis (mouse pneumonitis) lung infection. J Immunol (1998) 1.56

Global WHO Alliance for the Elimination of Blinding Trachoma by 2020. Wkly Epidemiol Rec (2012) 1.54

The Chlamydia type III secretion system C-ring engages a chaperone-effector protein complex. PLoS Pathog (2009) 1.52

Tyrosine phosphorylation of the chlamydial effector protein Tarp is species specific and not required for recruitment of actin. Infect Immun (2005) 1.50

Diversity of bacteria at healthy human conjunctiva. Invest Ophthalmol Vis Sci (2011) 1.50

The p47 GTPases Igtp and Irgb10 map to the Chlamydia trachomatis susceptibility locus Ctrq-3 and mediate cellular resistance in mice. Proc Natl Acad Sci U S A (2006) 1.49

Biogeography of the ecosystems of the healthy human body. Genome Biol (2013) 1.48

Unity in variety--the pan-genome of the Chlamydiae. Mol Biol Evol (2011) 1.47

Scarring trachoma is associated with polymorphism in the tumor necrosis factor alpha (TNF-alpha) gene promoter and with elevated TNF-alpha levels in tear fluid. Infect Immun (1997) 1.45

HLA antigens in Omanis with blinding trachoma: markers for disease susceptibility and resistance. Br J Ophthalmol (1997) 1.45

Recombination in the genome of Chlamydia trachomatis involving the polymorphic membrane protein C gene relative to ompA and evidence for horizontal gene transfer. J Bacteriol (2004) 1.44

The arrested immunity hypothesis and the epidemiology of chlamydia control. Sex Transm Dis (2008) 1.44

The p47 GTPases Iigp2 and Irgb10 regulate innate immunity and inflammation to murine Chlamydia psittaci infection. J Immunol (2007) 1.40

Specific chlamydial inclusion membrane proteins associate with active Src family kinases in microdomains that interact with the host microtubule network. Cell Microbiol (2010) 1.40

Recruitment of BAD by the Chlamydia trachomatis vacuole correlates with host-cell survival. PLoS Pathog (2006) 1.36

Hypervirulent Chlamydia trachomatis clinical strain is a recombinant between lymphogranuloma venereum (L(2)) and D lineages. MBio (2011) 1.36

Analysis of putative Chlamydia trachomatis chaperones Scc2 and Scc3 and their use in the identification of type III secretion substrates. J Bacteriol (2005) 1.33

HLA DQ alleles and interleukin-10 polymorphism associated with Chlamydia trachomatis-related tubal factor infertility: a case-control study. Hum Reprod (2002) 1.29

High-resolution genotyping of Chlamydia trachomatis from recurrent urogenital infections. J Clin Microbiol (2000) 1.28

Why do bacteria engage in homologous recombination? Trends Microbiol (2009) 1.23

Type I interferon signaling exacerbates Chlamydia muridarum genital infection in a murine model. Infect Immun (2008) 1.23

Antibiotic resistance in Chlamydiae. Future Microbiol (2010) 1.22

The ompA gene in Chlamydia trachomatis differs in phylogeny and rate of evolution from other regions of the genome. Infect Immun (2006) 1.22

A coding polymorphism in matrix metalloproteinase 9 reduces risk of scarring sequelae of ocular Chlamydia trachomatis infection. BMC Med Genet (2006) 1.21

The Swedish new variant of Chlamydia trachomatis: genome sequence, morphology, cell tropism and phenotypic characterization. Microbiology (2010) 1.21

Chlamydia trachomatis tarp is phosphorylated by src family tyrosine kinases. Biochem Biophys Res Commun (2008) 1.21

Risk of trachomatous scarring and trichiasis in Gambians varies with SNP haplotypes at the interferon-gamma and interleukin-10 loci. Genes Immun (2005) 1.21

Divergence without difference: phylogenetics and taxonomy of Chlamydia resolved. FEMS Immunol Med Microbiol (2009) 1.19

Diversity within inc genes of clinical Chlamydia trachomatis variant isolates that occupy non-fusogenic inclusions. Microbiology (2002) 1.19

Multi-genome identification and characterization of chlamydiae-specific type III secretion substrates: the Inc proteins. BMC Genomics (2011) 1.18

Variability of the Chlamydia trachomatis omp1 gene detected in samples from men tested in male-only saunas in Melbourne, Australia. J Clin Microbiol (2004) 1.17

Gene duplication, the evolution of novel gene functions, and detecting functional divergence of duplicates in silico. Appl Bioinformatics (2003) 1.16

Genetic analysis of susceptibility to Chlamydia trachomatis in mouse. Genes Immun (2006) 1.14

The conserved Tarp actin binding domain is important for chlamydial invasion. PLoS Pathog (2010) 1.14

Genetic variation at the TNF locus and the risk of severe sequelae of ocular Chlamydia trachomatis infection in Gambians. Genes Immun (2007) 1.13

Summary: The natural history and immunobiology of Chlamydia trachomatis genital infection and implications for Chlamydia control. J Infect Dis (2010) 1.12

Effect of interferon on a primary conjunctival epithelial cell model of trachoma. Invest Ophthalmol Vis Sci (1991) 1.11

Dynamic diversity of the tryptophan pathway in chlamydiae: reductive evolution and a novel operon for tryptophan recapture. Genome Biol (2002) 1.11

Chlamydia trachomatis control requires a vaccine. Vaccine (2013) 1.10

Chlamydia trachomatis strains and virulence: rethinking links to infection prevalence and disease severity. J Infect Dis (2010) 1.09

A new genetic variant of Chlamydia trachomatis. Sex Transm Infect (2007) 1.08

Evolution and conservation of predicted inclusion membrane proteins in chlamydiae. Comp Funct Genomics (2012) 1.08

T cell responses in the absence of IFN-gamma exacerbate uterine infection with Chlamydia trachomatis. J Immunol (2009) 1.07

CXCR3 and CCR5 are both required for T cell-mediated protection against C. trachomatis infection in the murine genital mucosa. Mucosal Immunol (2010) 1.06

Tarp regulates early Chlamydia-induced host cell survival through interactions with the human adaptor protein SHC1. J Cell Biol (2010) 1.06

Evolution by leaps: gene duplication in bacteria. Biol Direct (2009) 1.06